ADAM8
Basic information
Region (hg38): 10:133262420-133276868
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAM8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 69 | 13 | 86 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 69 | 19 | 5 |
Variants in ADAM8
This is a list of pathogenic ClinVar variants found in the ADAM8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-133263172-G-A | not specified | Uncertain significance (Feb 08, 2023) | ||
10-133263173-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
10-133263179-C-G | not specified | Uncertain significance (Nov 13, 2023) | ||
10-133263224-C-G | not specified | Uncertain significance (Jun 03, 2024) | ||
10-133263233-C-T | not specified | Likely benign (Aug 19, 2023) | ||
10-133263735-G-C | not specified | Uncertain significance (Aug 31, 2022) | ||
10-133263747-C-G | not specified | Uncertain significance (Jan 24, 2024) | ||
10-133263747-C-T | Benign (May 15, 2018) | |||
10-133263752-G-A | not specified | Uncertain significance (Jun 08, 2022) | ||
10-133267368-C-T | not specified | Likely benign (Oct 03, 2022) | ||
10-133267397-G-T | not specified | Likely benign (Jan 24, 2024) | ||
10-133267409-G-A | not specified | Likely benign (Dec 19, 2023) | ||
10-133267939-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
10-133267956-C-T | not specified | Likely benign (Dec 22, 2023) | ||
10-133267962-G-A | not specified | Likely benign (May 22, 2023) | ||
10-133267979-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
10-133268035-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
10-133268049-C-T | not specified | Likely benign (Apr 01, 2024) | ||
10-133268057-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
10-133268089-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
10-133268107-G-T | not specified | Uncertain significance (Nov 14, 2023) | ||
10-133268775-C-T | not specified | Uncertain significance (Nov 21, 2023) | ||
10-133268845-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
10-133268862-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
10-133269471-G-A | not specified | Uncertain significance (Oct 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADAM8 | protein_coding | protein_coding | ENST00000445355 | 23 | 14466 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.20e-14 | 0.821 | 124578 | 4 | 897 | 125479 | 0.00360 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.380 | 467 | 491 | 0.952 | 0.0000326 | 5210 |
Missense in Polyphen | 186 | 192.94 | 0.96401 | 2104 | ||
Synonymous | -1.26 | 241 | 217 | 1.11 | 0.0000162 | 1670 |
Loss of Function | 1.94 | 28 | 41.5 | 0.675 | 0.00000204 | 472 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00377 | 0.00375 |
Ashkenazi Jewish | 0.0152 | 0.0145 |
East Asian | 0.00709 | 0.00699 |
Finnish | 0.000707 | 0.000693 |
European (Non-Finnish) | 0.00394 | 0.00385 |
Middle Eastern | 0.00709 | 0.00699 |
South Asian | 0.00135 | 0.00131 |
Other | 0.00585 | 0.00573 |
dbNSFP
Source:
- Function
- FUNCTION: Possible involvement in extravasation of leukocytes.;
- Pathway
- Neutrophil degranulation;Extracellular matrix organization;Innate Immune System;Immune System;Degradation of the extracellular matrix;Alpha9 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.143
Haploinsufficiency Scores
- pHI
- 0.354
- hipred
- N
- hipred_score
- 0.172
- ghis
- 0.474
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adam8
- Phenotype
- normal phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- adam8a
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- increased accumulation
Gene ontology
- Biological process
- cell morphogenesis;angiogenesis;leukocyte migration involved in inflammatory response;positive regulation of acute inflammatory response;proteolysis;inflammatory response;positive regulation of protein processing;regulation of cell-cell adhesion;extracellular matrix disassembly;positive regulation of T cell differentiation in thymus;neutrophil degranulation;positive regulation of MAP kinase activity;negative regulation of neuron apoptotic process;positive regulation of innate immune response;positive regulation of bone resorption;positive regulation of cell adhesion;lymphocyte chemotaxis;positive regulation of protein secretion;positive regulation of membrane protein ectodomain proteolysis;positive regulation of NF-kappaB transcription factor activity;positive regulation of protein kinase B signaling;positive regulation of thymocyte apoptotic process;cellular response to hypoxia;cell-cell adhesion;positive regulation of tumor necrosis factor (ligand) superfamily member 11 production;positive regulation of neutrophil extravasation;positive regulation of fibronectin-dependent thymocyte migration;positive regulation of eosinophil migration
- Cellular component
- podosome;cytoplasm;plasma membrane;integral component of plasma membrane;cell surface;phagolysosome;dense core granule membrane;specific granule membrane;specific granule;tertiary granule;tertiary granule membrane;alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;alpha9-beta1 integrin-ADAM8 complex;ficolin-1-rich granule membrane
- Molecular function
- metalloendopeptidase activity;serine-type endopeptidase activity;calcium ion binding;protein binding;metallopeptidase activity;zinc ion binding;protein self-association;cell adhesion molecule binding